CDC Vaccine Safety Chief Under Fire for Alleged Document Destruction [WATCH]

Senator Ron Johnson (R-WI), chairman of the Senate’s Permanent Subcommittee on Investigations, is conducting a probe into whether Dr. Tom Shimabukuro of the Centers for Disease Control and Prevention (CDC) improperly deleted records related to known risks associated with COVID-19 vaccines.

According to Johnson, Shimabukuro — who leads the CDC’s Immunization Safety Office and served as a key figure in the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink — may have destroyed subpoenaed materials that were under federal preservation orders. Johnson shared details of the investigation Monday on Just the News, No Noise.

CDC Deputy Director Admits COVID Jabs Are Causing Debilitating Illnesses

“We understand that illness is disruptive and stressful, especially under those circumstances” – Tom Shimabukuro

H/T @TheChiefNerd pic.twitter.com/sskh0VVYxZ

— RVM News (@redvoicenews) January 27, 2023

Trump’s Sovereign Wealth Fund: What Could It Mean For Your Money?

“He was central to safety surveillance” for the COVID-19 vaccines, Johnson said, referencing Shimabukuro’s role in briefing CDC and Food and Drug Administration (FDA) advisory panels prior to major vaccine policy decisions.

This Could Be the Most Important Video Gun Owners Watch All Year

Johnson expressed frustration with a lack of cooperation from federal health agencies and said his subcommittee was unable to confirm whether Shimabukuro still works at the CDC.

On April 9, Johnson sent a letter to Attorney General Pam Bondi, FBI Director Kash Patel, and HHS Principal Deputy Inspector General Juliet Hodgkins, stating that HHS informed his office on March 19 that Shimabukuro’s records “remain lost and, potentially, removed” from government systems.

Johnson said this could constitute a violation of the Federal Records Act and directly obstructs his ongoing investigation into COVID-19 vaccine oversight.

The investigation follows the release of a May 21 interim report by the subcommittee, which includes unredacted documents obtained through Freedom of Information Act (FOIA) litigation.

Among them was a “17-page talking points memo” that had previously been released in redacted form.

Johnson said the full version revealed that federal health officials were aware of myocarditis risks linked to mRNA COVID-19 vaccines earlier than publicly acknowledged.

Johnson noted that U.S. officials were alerted by Israeli authorities in February 2021 about early myocarditis cases.

Internally, agencies debated whether to issue a Health Alert Network warning but ultimately opted for a lower-level notice that omitted guidance for physicians treating affected individuals, such as advising patients to avoid strenuous exercise.

The senator said his committee has issued over 70 oversight letters seeking transparency on vaccine safety but has repeatedly been ignored.

Johnson said his team now relies on external litigation to access government documents that are frequently redacted or withheld.

Shimabukuro’s public acknowledgment of myocarditis and pericarditis risks in young adults came months after college campuses implemented vaccine mandates.

In June 2021, he presented data to the FDA’s Vaccines and Related Biological Products Advisory Committee showing that individuals aged 12 to 24 accounted for more than half of myocarditis and pericarditis reports despite receiving only 9% of mRNA vaccines — nearly triple the expected rate.

In October 2023, Shimabukuro presented additional findings suggesting an elevated risk of ischemic stroke in adults 65 and older who received the Pfizer COVID-19 vaccine and flu shot on the same day.

This data contradicted earlier CDC recommendations encouraging simultaneous vaccinations.

Former FDA officials have also raised concerns. Dr. Peter Marks, who led the FDA’s Center for Biologics Evaluation and Research until his departure this spring, said last fall that he would likely separate flu and COVID vaccine doses by at least two weeks to reduce the risk of side effects and interactions.

Dr. Philip Krause, former deputy director of the FDA’s Office of Vaccines Research and Review, testified to Congress in 2023 that he chose not to receive a booster due to the observed 1-in-5,000 rate of heart inflammation in young males.

Krause and his former supervisor, Dr. Marion Gruber, both opposed fast-tracking full vaccine approval and booster authorization and were later sidelined.

The investigation into Shimabukuro is ongoing.

Connect with Vetted Off-Duty Cops to Instantly Fulfill Your Security Needs